Ryerson (RYZ) Q3 2026 Earnings Call Transcript

Ryerson reported Q3 2026 revenue of $2.18B, up 8.6% sequentially, and adjusted EBITDA excluding LIFO of $115M, above its $88M–$92M guidance; net income rose to $32.0M from $15.5M in Q2. Shipments increased 1.2% sequentially versus guidance for a 3%–5% seasonal decline, while Olympic Steel contributed $30.2M in adjusted EBITDA and merger synergies reached a $52M annualized run rate, ahead of the initial $40M target. Gross margin contracted 50 bps to 17.2% amid higher material costs and pricing lags; Q4 revenue guidance is $1.96B–$2.04B and adjusted EBITDA excluding LIFO is $100M–$104M. The company returned $3.8M through share repurchases and maintained its $0.1875 quarterly dividend.

Analysis

The bullish read-through is less about a strong quarter than about mix and execution: incremental transactional pounds appear to earn materially more than program volume, while the merged inventory network may improve the ability to capture that spread. If the spread persists through 2027 contract resets, earnings power can improve beyond procurement and headcount savings. But tight hot-roll supply is double-edged: it supports replacement prices and the value of stocked inventory, while raising working-capital needs and increasing the risk that program pricing resets lag costs. The $30 million quarterly LIFO charge and cash absorbed by working capital make EBITDA a cleaner operating signal than reported net income, but not a substitute for cash conversion.

Near term, seasonal shipment declines and lower guided net income may cap enthusiasm; the key 1–3 month test is whether transactional mix and gross margin hold as October momentum meets holiday seasonality. Over 6–18 months, integration execution and the promised synergy run-rate matter, but management targets are not realized cash flow. Leverage is improving partly through higher trailing EBITDA; debt rose with working capital, so a reversal in steel prices or demand could expose balance-sheet sensitivity. Data-center demand is a useful offset, not yet proof of a broad industrial recovery. Consensus may over-credit synergy targets and underweight inventory-cycle risk; absent valuation and post-call price action, the results alone do not justify chasing.

Key Decisions for Investors

• Own RYZ only as a measured cyclical/integration position; prefer staged entry after the initial earnings reaction rather than chasing, with sizing contingent on valuation and liquidity. Reassess if adjusted gross margin continues to contract or leverage fails to fall below 3.0x as guided.
• Track quarterly transactional-versus-program mix, gross margin excluding LIFO and purchase accounting, and operating cash flow. A sustained widening of the transactional margin advantage without worsening cash conversion would validate incremental earnings leverage; margin compression alongside rising inventory or debt would falsify it.
• Treat tight hot-roll supply as a two-sided catalyst: it can support selling prices, but watch mill lead times, inventory days, and customer pass-through timing. A sharp easing in carbon pricing before program resets would weaken the near-term margin thesis.
• Do not underwrite the full $120 million synergy objective yet. Monitor realized savings, one-time integration costs, and completion of the Connecticut consolidation through Q1 2027; delayed execution or lower commercial synergies would challenge the merger premium to the standalone cyclical case.